NRX Pharmaceuticals (NRXP) Other Non Operating Income (2020 - 2024)
NRX Pharmaceuticals' (NRXP) quarterly Other Non Operating Income came in at -$9000.0 in Q1 2024, down 175.0% year-on-year from $12000.0 in Q2 2023, and down 28.57% on a QoQ basis from -$7000.0 in Q4 2023.
NRX Pharmaceuticals (NRXP) Other Non Operating Income (2020 - 2024) Analysis & Trends
NRX Pharmaceuticals (NRXP) has 5 years of Other Non Operating Income data on file, last reported at -$9000.0 in Q1 2024.
- On a quarterly basis, Other Non Operating Income fell 175.0% year-over-year to -$9000.0 in Q1 2024; TTM through Mar 2024 was -$1000.0, a 100.91% decrease from a year earlier, with the FY2023 full-year figure at $20000.0, down 92.16% from the prior year.
- Other Non Operating Income for Q1 2024 stood at -$9000.0, down from -$7000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for NRXP reached as high as $17.4 million in Q2 2021 and fell as low as -$16.5 million in Q3 2021.
- Historically, Other Non Operating Income has averaged $198582.9 across 5 years, with a median of $15500.0 in 2022.
- Across the five-year window, Other Non Operating Income surged 981775.0% in 2021 and sank 175.0% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at $160.0 in 2020, then jumped by 981775.0% to $1.6 million in 2021, then tumbled by 98.79% to $19000.0 in 2022, then plunged by 136.84% to -$7000.0 in 2023, then slipped by 28.57% to -$9000.0 in 2024.
- Per Business Quant data, the three most recent Other Non Operating Income figures were -$9000.0 in Q1 2024, -$7000.0 in Q4 2023, and $26000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | NRX Pharmaceuticals | 137.57 Mn | 130.87 Mn | 437,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | -9,000.00 |
| Dec 31, 2023 | -7,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | -11,000.00 |
| Mar 31, 2023 | 12,000.00 |
| Dec 31, 2022 | 19,000.00 |
| Sep 30, 2022 | -37,000.00 |
| Jun 30, 2022 | 116,000.00 |
| Mar 31, 2022 | 157,000.00 |
| Dec 31, 2021 | 1.57 Mn |
| Sep 30, 2021 | -16.54 Mn |
| Jun 30, 2021 | 17.36 Mn |
| Mar 31, 2021 | 121,000.00 |
| Dec 31, 2020 | 160.00 |